712 related articles for article (PubMed ID: 27617574)
1. Disruption of the RP-MDM2-p53 pathway accelerates APC loss-induced colorectal tumorigenesis.
Liu S; Tackmann NR; Yang J; Zhang Y
Oncogene; 2017 Mar; 36(10):1374-1383. PubMed ID: 27617574
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic c-Myc-induced lymphomagenesis is inhibited non-redundantly by the p19Arf-Mdm2-p53 and RP-Mdm2-p53 pathways.
Meng X; Carlson NR; Dong J; Zhang Y
Oncogene; 2015 Nov; 34(46):5709-17. PubMed ID: 25823025
[TBL] [Abstract][Full Text] [Related]
3. RPL23 Links Oncogenic RAS Signaling to p53-Mediated Tumor Suppression.
Meng X; Tackmann NR; Liu S; Yang J; Dong J; Wu C; Cox AD; Zhang Y
Cancer Res; 2016 Sep; 76(17):5030-9. PubMed ID: 27402081
[TBL] [Abstract][Full Text] [Related]
4. The in vivo role of the RP-Mdm2-p53 pathway in signaling oncogenic stress induced by pRb inactivation and Ras overexpression.
Pan W; Issaq S; Zhang Y
PLoS One; 2011; 6(6):e21625. PubMed ID: 21747916
[TBL] [Abstract][Full Text] [Related]
5. An ARF-independent c-MYC-activated tumor suppression pathway mediated by ribosomal protein-Mdm2 Interaction.
Macias E; Jin A; Deisenroth C; Bhat K; Mao H; Lindström MS; Zhang Y
Cancer Cell; 2010 Sep; 18(3):231-43. PubMed ID: 20832751
[TBL] [Abstract][Full Text] [Related]
6. Protection against High-Fat-Diet-Induced Obesity in MDM2
Liu S; Kim TH; Franklin DA; Zhang Y
Cell Rep; 2017 Jan; 18(4):1005-1018. PubMed ID: 28122227
[TBL] [Abstract][Full Text] [Related]
7. The RP-Mdm2-p53 pathway and tumorigenesis.
Miliani de Marval PL; Zhang Y
Oncotarget; 2011 Mar; 2(3):234-8. PubMed ID: 21406728
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic MYC Induces the Impaired Ribosome Biogenesis Checkpoint and Stabilizes p53 Independent of Increased Ribosome Content.
Morcelle C; Menoyo S; Morón-Duran FD; Tauler A; Kozma SC; Thomas G; Gentilella A
Cancer Res; 2019 Sep; 79(17):4348-4359. PubMed ID: 31292158
[TBL] [Abstract][Full Text] [Related]
9. LUCAT1 promotes colorectal cancer tumorigenesis by targeting the ribosomal protein L40-MDM2-p53 pathway through binding with UBA52.
Zhou Q; Hou Z; Zuo S; Zhou X; Feng Y; Sun Y; Yuan X
Cancer Sci; 2019 Apr; 110(4):1194-1207. PubMed ID: 30690837
[TBL] [Abstract][Full Text] [Related]
10. microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis.
Zhang C; Liu J; Tan C; Yue X; Zhao Y; Peng J; Wang X; Laddha SV; Chan CS; Zheng S; Hu W; Feng Z
Oncotarget; 2016 Feb; 7(8):8783-96. PubMed ID: 26840028
[TBL] [Abstract][Full Text] [Related]
11. Ribosomal protein-Mdm2-p53 pathway coordinates nutrient stress with lipid metabolism by regulating MCD and promoting fatty acid oxidation.
Liu Y; He Y; Jin A; Tikunov AP; Zhou L; Tollini LA; Leslie P; Kim TH; Li LO; Coleman RA; Gu Z; Chen YQ; Macdonald JM; Graves LM; Zhang Y
Proc Natl Acad Sci U S A; 2014 Jun; 111(23):E2414-22. PubMed ID: 24872453
[TBL] [Abstract][Full Text] [Related]
12. Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling.
Moon BS; Jeong WJ; Park J; Kim TI; Min do S; Choi KY
J Natl Cancer Inst; 2014 Feb; 106(2):djt373. PubMed ID: 24491301
[TBL] [Abstract][Full Text] [Related]
13. DRO1 inactivation drives colorectal carcinogenesis in ApcMin/+ mice.
Grill JI; Neumann J; Herbst A; Hiltwein F; Ofner A; Marschall MK; Wolf E; Kirchner T; Göke B; Schneider MR; Kolligs FT
Mol Cancer Res; 2014 Nov; 12(11):1655-62. PubMed ID: 25053805
[TBL] [Abstract][Full Text] [Related]
14. GRWD1 negatively regulates p53 via the RPL11-MDM2 pathway and promotes tumorigenesis.
Kayama K; Watanabe S; Takafuji T; Tsuji T; Hironaka K; Matsumoto M; Nakayama KI; Enari M; Kohno T; Shiraishi K; Kiyono T; Yoshida K; Sugimoto N; Fujita M
EMBO Rep; 2017 Jan; 18(1):123-137. PubMed ID: 27856536
[TBL] [Abstract][Full Text] [Related]
15. Ribosomal protein RPL11 haploinsufficiency causes anemia in mice via activation of the RP-MDM2-p53 pathway.
Franklin DA; Liu S; Jin A; Cui P; Guo Z; Arend KC; Moorman NJ; He S; Wang GG; Wan YY; Zhang Y
J Biol Chem; 2023 Jan; 299(1):102739. PubMed ID: 36435197
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of intestinal polyposis with reduced angiogenesis in ApcMin/+ mice due to decreases in c-Myc expression.
Yekkala K; Baudino TA
Mol Cancer Res; 2007 Dec; 5(12):1296-303. PubMed ID: 18171987
[TBL] [Abstract][Full Text] [Related]
17. Mice with a Mutation in the Mdm2 Gene That Interferes with MDM2/Ribosomal Protein Binding Develop a Defect in Erythropoiesis.
Kamio T; Gu BW; Olson TS; Zhang Y; Mason PJ; Bessler M
PLoS One; 2016; 11(4):e0152263. PubMed ID: 27042854
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-494 promotes cancer progression and targets adenomatous polyposis coli in colorectal cancer.
Zhang Y; Guo L; Li Y; Feng GH; Teng F; Li W; Zhou Q
Mol Cancer; 2018 Jan; 17(1):1. PubMed ID: 29304823
[TBL] [Abstract][Full Text] [Related]
19. Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis.
Eischen CM; Roussel MF; Korsmeyer SJ; Cleveland JL
Mol Cell Biol; 2001 Nov; 21(22):7653-62. PubMed ID: 11604501
[TBL] [Abstract][Full Text] [Related]
20. SPIN1 promotes tumorigenesis by blocking the uL18 (universal large ribosomal subunit protein 18)-MDM2-p53 pathway in human cancer.
Fang Z; Cao B; Liao JM; Deng J; Plummer KD; Liao P; Liu T; Zhang W; Zhang K; Li L; Margolin D; Zeng SX; Xiong J; Lu H
Elife; 2018 Mar; 7():. PubMed ID: 29547122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
